ConductScience.org, home

Paper41249572

DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth.

Williams AF and 13 others. Nat Cell Biol, 2025. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth. Papers, record 41249572. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41249572

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth.
PubMed
Journal
Nat Cell Biol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.25, provisional
iCite
Revised in PubMed
2026-11-02
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Williams AFAugust Fhttps://orcid.org/0000-0003-1994-2033
2Gervasio DAGDavid A G
3Turkal CEClaire E
4Stuhlfire AEAnna Ehttps://orcid.org/0000-0002-9303-3295
5Wang MXMichael Xhttps://orcid.org/0000-0001-7937-8708
6Mauch BEBrandon E
7Plawat RRheahttps://orcid.org/0009-0001-4674-0333
8Nguyen AHAriel Hhttps://orcid.org/0000-0002-2525-8011
9Paw MHMichelle H
10Hairani MMehrshadhttps://orcid.org/0009-0005-1790-9776
11Lathrop CPCooper P
12Harris SHSophie H
13Page JLJennifer Lhttps://orcid.org/0000-0002-5822-0298
14Hangauer MJMatthew Jhttps://orcid.org/0000-0002-5008-6696

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Interferon Type IMajor topic
Humans
Apoptosis
Activating Transcription Factor 3
Signal Transduction
Cell Line, Tumor
Drug Resistance, Neoplasm
Animals
DNA Damage
Mice
Gene Expression Regulation, Neoplastic
Cell Proliferation
Antineoplastic Agents

Source PubMed

Download CSV of topics

Grants12

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
IRG-19-230-48-IRGAmerican Cancer Society (American Cancer Society, Inc.)PubMedPubMed
CA212767U.S. Department of Health & Human Services | National Institutes of Health (NIH)R01CA212767PubMed and NIHNIH RePORTER
S10 OD026929NIH HHSUnited StatesS10OD026929PubMed and NIHNIH RePORTER
P30 CA023100NCI NIH HHSUnited StatesP30CA023100PubMed and NIHNIH RePORTER
P30 AI036214NIAID NIH HHSUnited StatesP30AI036214PubMed and NIHNIH RePORTER
689282Melanoma Research Alliance (MRA)PubMedPubMed
CA067754U.S. Department of Health & Human Services | National Institutes of Health (NIH)T32CA067754PubMed and NIHNIH RePORTER
V2021-035V Foundation for Cancer Research (V Foundation)PubMedPubMed
CA009523U.S. Department of Health & Human Services | National Institutes of Health (NIH)T32CA009523PubMed and NIHNIH RePORTER
ME230211United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (CDMRP)PubMedPubMed
T32 CA067754NCI NIH HHSUnited StatesT32CA067754PubMed and NIHNIH RePORTER
T32 CA009523NCI NIH HHSUnited StatesT32CA009523PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of40894800

Source PubMed

Download CSV of comments and corrections

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119451168Fast and accurate short read alignment with Burrows-Wheeler transform.Bioinformatics2009https://conductscience.org/library/papers/19451168PubMed
232521256Failed Apoptosis Enhances Melanoma Cancer Cell Aggressiveness.Cell Rep2020https://conductscience.org/library/papers/32521256PubMed
335353542Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells.Sci Transl Med2022https://conductscience.org/library/papers/35353542PubMed
430341162Maftools: efficient and comprehensive analysis of somatic variants in cancer.Genome Res2018https://conductscience.org/library/papers/30341162PubMed
526891683Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells.Nat Commun2016https://conductscience.org/library/papers/26891683PubMed
619478064Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19478064PubMed
736997393Self-inflicted DNA breaks in cell differentiation and cancer.Trends Cell Biol2023https://conductscience.org/library/papers/36997393PubMed
826430063Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells.Genome Res2015https://conductscience.org/library/papers/26430063PubMed
933741929Melanoma subpopulations that rapidly escape MAPK pathway inhibition incur DNA damage and rely on stress signalling.Nat Commun2021https://conductscience.org/library/papers/33741929PubMed
1020639907TRAIL treatment provokes mutations in surviving cells.Oncogene2010https://conductscience.org/library/papers/20639907PubMed
1128981092Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine.Cell Death Dis2017https://conductscience.org/library/papers/28981092PubMed
1234320411Establishment, maintenance, and recall of inflammatory memory.Cell Stem Cell2021https://conductscience.org/library/papers/34320411PubMed
1337821702Apoptotic stress causes mtDNA release during senescence and drives the SASP.Nature2023https://conductscience.org/library/papers/37821702PubMed
1430997620Proteasome inhibitors trigger mutations via activation of caspases and CAD, but mutagenesis provoked by the HDAC inhibitors vorinostat and romidepsin is caspase/CAD-independent.Apoptosis2019https://conductscience.org/library/papers/30997620PubMed
159770511Resistance to DNA fragmentation and chromatin condensation in mice lacking the DNA fragmentation factor 45.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9770511PubMed
1610318789Activation of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease). Oligomerization and direct interaction with histone H1.J Biol Chem1999https://conductscience.org/library/papers/10318789PubMed
1732499442MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer.Science2020https://conductscience.org/library/papers/32499442PubMed
1820371346A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.Cell2010https://conductscience.org/library/papers/20371346PubMed
1936991128STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma.Nature2023https://conductscience.org/library/papers/36991128PubMed
2024600036PIKfyve, a class III lipid kinase, is required for TLR-induced type I IFN production via modulation of ATF3.J Immunol2014https://conductscience.org/library/papers/24600036PubMed

See all 70 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42923094Epigenetic adaptations and vulnerabilities in ovarian cancer drug-tolerant persister cells.NAR Cancer2026https://conductscience.org/library/papers/42923094PubMed
42814839Tumor gasdermin E acts as a rheostat to limit apoptotic cell survival and mutagenesis in anticancer immune environments.Sci Adv2026https://conductscience.org/library/papers/42814839PubMed
42690507Evasion of cell death despite mitochondrial outer membrane permeabilization: an oncogenic outcome of apoptosis.Apoptosis2026https://conductscience.org/library/papers/42690507PubMed
42539880Targeting tumor transition windows.Explor Target Antitumor Ther2026https://conductscience.org/library/papers/42539880PubMed
42360409Multidrug resistance in cancer: current understandings and future perspective.Mol Biomed2026https://conductscience.org/library/papers/42360409PubMed
41761000DLX2 marks an immunosuppressive dendritic-cell program that reshapes cytotoxic immunity and marks a tolerogenic microenvironment in lung adenocarcinoma.Discov Oncol2026https://conductscience.org/library/papers/41761000PubMed
41542583A kinome inhibitor screen implicates adhesion and growth factor signaling in cellular recovery after caspase activation.bioRxiv2026https://conductscience.org/library/papers/41542583PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ATF3467PubTator's text mininghttps://conductscience.org/library/genes/467NCBI Gene
DFFB1677PubTator's text mininghttps://conductscience.org/library/genes/1677NCBI Gene
JUNB3726PubTator's text mininghttps://conductscience.org/library/genes/3726NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41249572

GET https://conductscience.org/api/papers/v1/41249572/references?page=2